ReportAlert.info - Merck KGaA (FRA:MRK) Publishes its Sixth Corporate Responsibility Report
The report has attained an A+ application level as defined by the guidelines of the Global Reporting Initiative.
May 2, 2013 /3BL Media/ - Merck KGaA of Darmstadt, Germany, has published its sixth Corporate Responsibility Report, covering the years 2011 and 2012. It is available online at www.merckgroup.com/cr-report2012.
At Merck, responsible conduct is embedded in its fundamental principles of corporate governance and is an integral element of our corporate strategy. In this vein, Merck meets global challenges in a variety of ways, such as by improving access to medicines especially in developing health care systems, by developing sustainable products, by combating the neglected tropical disease schistosomiasis in Africa, by engaging in climate protection activities, and by promoting workforce diversity.
With this report, Merck has attained an A+ application level as defined by the guidelines of the Global Reporting Initiative. Also, Merck has obtained an independent audit certificate (limited assurance) for the non-financial key performance indicators from an external auditor. The report also documents the company’s progress in implementing the principles of the United Nations Global Compact.
Moreover, Merck has published a brochure featuring highlights of particular topics from the full report. To make comments or order a hard copy of the Highlights brochure, please contact corpcom@merck.de.
About Merck
Merck is a global pharmaceutical, chemical and life science company with total sales of nearly € 11 billion in 2012 and a history that began in 1668. Approximately 39,000 employees at 203 companies in 66 countries contribute to shaping our future. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
